Overview

Boiled Peanut Oral Immunotherapy

Status:
Enrolling by invitation

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize that the proportion of subjects successfully desensitized with boiled peanut OIT is greater than the theoretical placebo rate of 20%.

Phase:

Phase 1

Details

Lead Sponsor:

Alton Melton
The Cleveland Clinic

Collaborator:

The Cleveland Clinic

Treatments:

Immunologic Factors